Baxter International Inc. $BAX Shares Newly Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. bought a new position in shares of Baxter International Inc. (NYSE:BAX – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 64,604 shares of the medical instruments supplier’s stock, valued at approximately $1,550,000.

A number of other institutional investors have also recently modified their holdings of BAX. BlackRock Inc. purchased a new position in shares of Baxter International in the 2nd quarter valued at about $1,744,874,000. Pzena Investment Management LLC acquired a new position in Baxter International in the 2nd quarter worth about $1,392,098,000. Equity Investment Corp acquired a new position in Baxter International in the 2nd quarter worth about $146,815,000. Bank of America Corp DE acquired a new position in Baxter International in the 2nd quarter worth about $132,993,000. Finally, Bank of New York Mellon Corp acquired a new position in Baxter International in the 2nd quarter worth about $68,036,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Baxter International Trading Down 0.2%

BAX stock opened at $25.77 on Monday. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The business’s 50-day moving average is $24.54 and its 200 day moving average is $21.67. The company has a current ratio of 1.79, a quick ratio of 1.19 and a debt-to-equity ratio of 1.20. The stock has a market cap of $13.33 billion, a price-to-earnings ratio of -18.28, a PEG ratio of 3.79 and a beta of 0.68.

Baxter International (NYSE:BAX – Get Free Report) last announced its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business had revenue of $2.98 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the prior year, the firm earned $0.69 earnings per share. The business’s revenue was up 5.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Baxter International Inc. will post 2.10 EPS for the current fiscal year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, November 27th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Baxter International’s payout ratio is currently -2.84%.

Analyst Ratings Changes

A number of equities analysts have issued reports on BAX shares. Wall Street Zen upgraded Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. TD Cowen boosted their price objective on Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Barclays boosted their price objective on Baxter International from $20.00 to $23.00 and gave the company an “underweight” rating in a research report on Monday, November 9th. Jefferies Financial Group reaffirmed a “hold” rating and set a $25.00 target price on shares of Baxter International in a research note on Thursday, October 29th. Finally, JPMorgan Chase & Co. decreased their target price on Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a research report on Friday, October 30th. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $23.27.

View Our Latest Stock Report on Baxter International

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Recommended Stories

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.